Answers are grounded in this paper and cite their sources.
Review highlights aptamer-based biosensing platforms for malaria detection, indicating strong potential for low-cost, sensitive point-of-care diagnostics in global disease management.
Malaria remains one of the most significant infectious diseases worldwide, requiring rapid, sensitive, and accessible diagnostic tools to improve disease management and control. Conventional diagnostic methods, including microscopy, rapid diagnostic tests, and nucleic acid amplification techniques, present limitations in sensitivity, specificity, cost, or field applicability. This review examines the emerging role of aptamer-based biosensors (aptasensors) as innovative alternatives for malaria detection. Aptamers are synthetic nucleic acid ligands that offer high affinity and specificity toward malaria biomarkers while providing advantages over antibodies, including improved stability, lower production costs, and ease of chemical modification. The review discusses aptamer selection methodologies, major Plasmodium biomarkers targeted for detection, and the integration of aptamers into electrochemical, optical, magnetic, and microfluidic biosensing platforms. Current advances demonstrate the potential of aptasensors to enable highly sensitive, selective, and portable point-of-care diagnostics for malaria surveillance and management.
No takes yet. Share an insight, caveat, or question.
Centelles et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: